Keelyn Ericson, MD
Nephrology · Topeka, KSNPI 1952327553
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for nephrology clinicians in KS, where the typical reported total is $931.
Across 16 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Enterprises LLC$53
- Novo Nordisk$42
- Vifor Pharma, Inc.$39
- AstraZeneca$38
- Akebia Therapeutics Inc$36
- Amarin Pharma, Inc.$13
- plus $35 from 3 others
What the payments were for
- Food & beverage$256100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Enterprises LLC | 3 | $53 |
| Novo Nordisk | 3 | $42 |
| Vifor Pharma, Inc. | 2 | $39 |
| AstraZeneca | 2 | $38 |
| Akebia Therapeutics Inc | 2 | $36 |
| Amarin Pharma, Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Otsuka America Pharmaceutical, Inc. | 1 | $11 |
How this compares
$256 in reported general payments places this provider in the 25th percentile of 55 nephrology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RenvelaSevelamer Carbonate | 11 | $15,275 |
| KerendiaFinerenone | 12 | $13,976 |
| VeltassaPatiromer Calcium Sorbitex | 13 | $11,457 |
| Cinacalcet Hcl | 13 | $7,593 |
| Sevelamer Carbonate | 29 | $2,791 |
| Potassium Citrate ErPotassium Citrate | 17 | $2,128 |
| ProsolParenteral Amino Acid 20% No.1 | 11 | $1,965 |
| Calcium Acetate | 36 | $1,775 |
| Midodrine Hcl | 22 | $790 |
| Calcitriol | 65 | $734 |
| Lisinopril | 76 | $662 |
| Carvedilol | 71 | $516 |
| Furosemide | 109 | $509 |
| Potassium Chloride | 12 | $471 |
| Amlodipine Besylate | 77 | $452 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Topeka
- Scott SolcherTopeka$46K
- Thomas AldersonTopeka$353
- Lakshmi DuvvurTopeka$326
- Edgard WehbeWichita$49K
- Aditi GuptaKansas City$16K
- Alan YuKansas City$16K
- Ahmad TuffahaKansas City$15K
- Brian PaveySalina$14K
- Diane CibrikKansas City$12K
- Dennis RossWichita$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.